Cardiac Science agrees $1.3 million sales:
This article was originally published in Clinica
Cardiac Science has been chosen to equip hospitals in Saudi Arabia, Turkey, Pakistan and Iran with 138 Artema patient monitors and 50 emergency defibrillators for a total of $1.3m. The Irvine, California-based company bought Artema Medical, of Stockholm, Sweden, in November 2001 (see Clinica No 986, p 16).
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.